CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%

CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% was reported 16 times

CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXPOSURE VIA DIRECT CONTACT 1 0.0011
1 EYE COLOUR CHANGE 1 0.0010
2 APPLICATION SITE PAPULES 1 0.0009
3 DARK CIRCLES UNDER EYES 1 0.0007
4 WRONG DRUG ADMINISTERED 3 0.0003
5 NAIL DISCOLOURATION 1 0.0003
6 APPLICATION SITE BURN 1 0.0002
7 EAR DISCOMFORT 2 0.0002
8 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
9 EAR PAIN 3 0.0002
10 VISUAL FIELD DEFECT 1 0.0001
11 NASAL DISCOMFORT 1 0.0001
12 SCAB 1 0.0001
13 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
14 OCULAR HYPERAEMIA 3 0.0001
15 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
16 APPLICATION SITE PAIN 1 0.0000
17 WOUND 1 0.0000
18 EYE IRRITATION 2 0.0000
19 IMPAIRED HEALING 1 0.0000
20 EXPIRED PRODUCT ADMINISTERED 1 0.0000
21 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
22 BURNING SENSATION 2 0.0000
23 EYE SWELLING 1 0.0000
24 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
25 THROAT IRRITATION 1 0.0000
26 SKIN DISCOLOURATION 1 0.0000
27 RASH ERYTHEMATOUS 1 0.0000
28 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
29 EYE PAIN 1 0.0000
30 BALANCE DISORDER 1 0.0000
31 OFF LABEL USE 10 0.0000
32 VISUAL IMPAIRMENT 1 0.0000
33 PRODUCT QUALITY ISSUE 1 0.0000
34 VISION BLURRED 1 0.0000
35 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
36 PRODUCT USE ISSUE 1 0.0000
37 ALOPECIA 1 0.0000
38 INSOMNIA 1 0.0000
39 PAIN 1 0.0000
40 HEADACHE 1 0.0000